Skip to main content
YOMA

The human studies behind our doses

Every study here was done in people, and each one sits behind a line we already print on this site: a dose, a form, a figure or a safety note.

We review it every quarter. See the new studies.

What puts a study on this page

  • It was done in people: a trial, a cohort, a measurement survey, or a review that pools published measurements. No animal or cell studies; where a paper also reports animal work, only its human part is described here.
  • It is peer-reviewed, and linked to the paper itself.
  • It is tied to a line we already print: a dose, a form, a prevalence figure or a safety note.
  • It is listed for what was measured, never as proof that YOMA does anything.
  • Nothing is listed for a claim a regulator refused.

Why some of our doses sit below the studies. Many trials give a large dose for weeks or months, often to people with a condition, to see whether anything moves. YOMA is built to be taken for years by healthy adults, so where a higher dose has no long-term safety record in healthy people, we chose a maintenance amount instead. The dose line on every card puts theirs next to ours, so you can see the gap for yourself.

Vitamin C

Why it matters here

  1. Prospective cohort

    23,355 people

    11 years

    Prospective cohort. 23,355 people. 11 years.
    The study in figures
    MeasureFigure
    DesignProspective cohort
    Size23,355 people
    How long11 years

    Studied in: Sweden

    Ascorbic acid supplements and kidney stone incidence among men: a prospective study

    Thomas et al., JAMA Internal Medicine, 2013

    Who
    Swedish men aged 45 to 79 at the start.
    What was measured
    First kidney stones in national registry records, by vitamin C supplement use.
    Why it is on our label
    The source of the vitamin C safety note we print. Vitamin C

    What it found

    Vitamin C supplements at 1,000 mg a day or more were associated with about twice the rate of kidney stones.

    Funded by
    Swedish public research funding.

    Read the paperDOI 10.1001/jamainternmed.2013.2296

What it did in people

  1. In-hospital depletion and repletion study

    7 people

    4 to 6 months

    In-hospital depletion and repletion study. 7 people. 4 to 6 months.
    The study in figures
    MeasureFigure
    DesignIn-hospital depletion and repletion study
    Size7 people
    How long4 to 6 months

    Dose 30 to 2,500 mg a day

    Ours 350 mg

    Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance

    Levine et al., Proceedings of the National Academy of Sciences, 1996

    Who
    Healthy volunteers, in hospital on a controlled diet.
    What was measured
    Vitamin C in plasma and in blood cells at seven daily doses.
    Why it is on our label
    The absorption data behind our vitamin C dose. Vitamin C

    What it found

    AbsorptionA single 200 mg dose was absorbed completely; from 500 mg absorption fell and the excess left in urine. Blood cells were full at 100 mg a day, plasma at 1,000 mg.

    In the bodyAt 1,000 mg a day, more oxalate and urate appeared in urine than at lower doses. Oxalate is a building block of the most common kidney stones; in the study above, 1,000 mg a day or more went with about twice the rate of kidney stones.

    Funded by
    No funding stated; the authors work at the US National Institutes of Health.

    Read the paperDOI 10.1073/pnas.93.8.3704

Vitamin D3

Why it matters here

  1. Pooled analysis

    7,947,359 people

    Studies from 2000 to 2022

    Pooled analysis. 7,947,359 people. Studies from 2000 to 2022.
    The study in figures
    MeasureFigure
    DesignPooled analysis
    Size7,947,359 people
    How longStudies from 2000 to 2022

    Pooled from 81 countries

    Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: a pooled analysis of 7.9 million participants

    Cui et al., Frontiers in Nutrition, 2023

    Who
    People aged one year or older, in population-based studies from 81 countries.
    What was measured
    The share below three blood vitamin D cut-offs, by world region.
    Why it is on our label
    The source of the Eastern Mediterranean figure we print. Vitamin D3

    What it found

    In the Eastern Mediterranean region, 71.8% were below 50 nmol/L of vitamin D.

    Funded by
    A Chinese provincial government grant.

    Read the paperDOI 10.3389/fnut.2023.1070808

  2. Retrospective records study

    22,335 people

    Records from 2017 to 2021

    Retrospective records study. 22,335 people. Records from 2017 to 2021.
    The study in figures
    MeasureFigure
    DesignRetrospective records study
    Size22,335 people
    How longRecords from 2017 to 2021

    Studied in: Majmaah, Saudi Arabia

    Prevalence and trends of vitamin D deficiency in a Saudi Arabian population: a five-years retrospective study from 2017 to 2021

    Madkhali et al., Frontiers in Public Health, 2025

    Who
    People tested at a hospital and at screening camps in Saudi Arabia, children included.
    What was measured
    Blood vitamin D in five years of records.
    Why it is on our label
    The source of the Saudi figure we print beside it. Vitamin D3

    What it found

    67.3% were below 30 ng/mL of vitamin D.

    Funded by
    A Saudi university research grant.

    Read the paperDOI 10.3389/fpubh.2025.1535980

What it did in people

  1. Randomised controlled trial

    76 people

    16 weeks

    Randomised controlled trial. 76 people. 16 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size76 people
    How long16 weeks

    Studied in: China

    Dose 0 to 2,000 IU a day

    Ours 3,000 IU, five days a week

    A dose-response study of vitamin D3 supplementation in healthy Chinese: a 5-arm randomized, placebo-controlled trial

    Yao et al., European Journal of Nutrition, 2016

    Who
    Healthy people in China.
    What was measured
    Blood vitamin D, as serum 25(OH)D, across five daily doses.
    Why it is on our label
    The dose-response trial behind the vitamin D figures we print. Our 3,000 IU on five days a week averages about 2,140 IU a day, close to its highest dose. Vitamin D3

    What it found

    AbsorptionBlood vitamin D started at 31.6 nmol/L on average. After 16 weeks it had risen by 6 on placebo, 26 at 800 IU and 36 at 2,000 IU a day, levelling off from about week six.

    Funded by
    Chinese government research grants.

    Read the paperDOI 10.1007/s00394-015-0859-4

Vitamin K2

What it did in people

  1. Placebo-controlled trial

    244 people

    3 years

    Placebo-controlled trial. 244 people. 3 years.
    The study in figures
    MeasureFigure
    DesignPlacebo-controlled trial
    Size244 people
    How long3 years

    Dose 180 mcg a day

    Ours 100 mcg

    Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women

    Knapen et al., Osteoporosis International, 2013

    Who
    Healthy postmenopausal women.
    What was measured
    Bone mineral density and bone strength by scan, and a blood marker of vitamin K status.
    Why it is on our label
    The adult K2 trial behind the vitamin K measurement we print, at 180 micrograms a day against our 100. Vitamin K2

    What it found

    AbsorptionA blood marker of vitamin K status (the share of osteocalcin left inactive) fell on MK-7, against placebo.

    In the bodyOn MK-7, the age-related decline in bone mineral density at the lumbar spine and femoral neck was smaller than on placebo; at the total hip it was not.

    Funded by
    The vitamin K2 maker.

    Read the paperDOI 10.1007/s00198-013-2325-6

  2. Randomised controlled trial

    115 people

    12 weeks

    Randomised controlled trial. 115 people. 12 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size115 people
    How long12 weeks

    Studied in: Tokyo, Japan

    Dose 100 mcg a day

    Ours 100 mcg

    Low-Dose Daily Intake of Vitamin K2 (Menaquinone-7) Improves Osteocalcin γ-Carboxylation: A Double-Blind, Randomized Controlled Trials

    Inaba et al., Journal of Nutritional Science and Vitaminology, 2015

    Who
    Healthy adults aged 20 to 69 in Japan.
    What was measured
    Active and inactive osteocalcin in the blood, a marker of vitamin K status.
    Why it is on our label
    The trial at our exact dose. Vitamin K2

    What it found

    AbsorptionAt 100 micrograms a day for 12 weeks, inactive osteocalcin fell and the ratio of active to inactive osteocalcin rose, against placebo.

    Funded by
    No outside funding; all three authors work for the maker of the ingredient tested.

    Read the paperDOI 10.3177/jnsv.61.471

Vitamin B12

Why it matters here

  1. Cross-sectional study

    3,432 people

    One measurement each

    Cross-sectional study. 3,432 people. One measurement each.
    The study in figures
    MeasureFigure
    DesignCross-sectional study
    Size3,432 people
    How longOne measurement each

    Studied in: Saudi Arabia

    The Prevalence of Vitamin and Mineral Deficiencies and High Levels of Non-Essential Heavy Metals in Saudi Arabian Adults

    Albalawi et al., Healthcare, 2022

    Who
    Adults across all 13 regions of Saudi Arabia.
    What was measured
    Blood levels of 14 micronutrients, B12 among them.
    Why it is on our label
    The source of the B12 figure we print. Vitamin B12

    What it found

    8.1% measured below the laboratory's reference range for B12.

    Funded by
    In part, two food and nutrition companies.

    Read the paperDOI 10.3390/healthcare10122415

  2. Review of published measurements

    18 articles

    Review of published measurements. 18 articles.
    The study in figures
    MeasureFigure
    DesignReview of published measurements
    Size18 articles

    How prevalent is vitamin B12 deficiency among vegetarians?

    Pawlak et al., Nutrition Reviews, 2013

    Who
    Vegetarians and vegans, by group: pregnant women, children, adolescents and older adults.
    What was measured
    Reported rates of B12 deficiency.
    Why it is on our label
    The source of the vegetarian B12 ranges we print. Vitamin B12

    What it found

    B12 deficiency among vegetarians: 62% of pregnant women, 25% to almost 86% of children, 21% to 41% of adolescents, 11% to 90% of older adults.

    Read the paperDOI 10.1111/nure.12001

Zinc

What it did in people

  1. Randomised controlled trial

    387 people

    6 months

    Randomised controlled trial. 387 people. 6 months.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size387 people
    How long6 months

    Pooled from 3 countries

    Dose 15 or 30 mg a day

    Ours 15 mg

    Age- and sex-dependent effects of long-term zinc supplementation on essential trace element status and lipid metabolism in European subjects: the Zenith Study

    Hininger-Favier et al., British Journal of Nutrition, 2007

    Who
    Adults aged 55 to 85 in Europe.
    What was measured
    Blood zinc and other trace elements, and blood fats.
    Why it is on our label
    The trial at our exact dose. Zinc

    What it found

    AbsorptionAt 15 mg a day for six months, zinc in blood serum rose significantly against placebo.

    Funded by
    The European Commission.

    Read the paperDOI 10.1017/S0007114507432974

Creatine monohydrate

What it did in people

  1. Randomised controlled trial

    42 people

    8 weeks

    Randomised controlled trial. 42 people. 8 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size42 people
    How long8 weeks

    Dose 0.25 g per kg of lean mass a day for 7 days, then 0.0625 g per kg for 49 days

    Ours 5 g

    Effect of creatine and weight training on muscle creatine and performance in vegetarians

    Burke et al., Medicine & Science in Sports & Exercise, 2003

    Who
    Vegetarians and non-vegetarians aged 19 to 55, training with weights.
    What was measured
    Creatine in thigh muscle samples, before and after eight weeks of creatine or placebo.
    Why it is on our label
    The comparison behind the creatine figures we print. Creatine monohydrate

    What it found

    AbsorptionMuscle creatine started at 117 in vegetarians and 130 in meat eaters (mmol per kg of dry muscle). After eight weeks it had risen more on creatine than on placebo, and most in the vegetarians.

    In the bodyOn the same training plan, the creatine groups gained more bench-press strength than placebo (85 to 101 kg, against 76 to 85 kg) and more lean tissue.

    On the doseA separate study of 31 men found the same rise in muscle creatine, about 20%, from 3 g a day over 28 days as from 20 g a day over 6 days: loading is faster, not greater.

    Hultman et al., Journal of Applied Physiology, 1996

    Funded by
    A creatine supplement maker.

    Read the paperDOI 10.1249/01.MSS.0000093614.17517.79

  2. Randomised controlled trial

    19 people

    12 weeks

    Randomised controlled trial. 19 people. 12 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size19 people
    How long12 weeks

    Dose 25 g a day for the first week, then 5 g a day

    Ours 5 g

    Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training

    Volek et al., Medicine & Science in Sports & Exercise, 1999

    Who
    Men already training with weights.
    What was measured
    Muscle creatine in thigh samples, body composition, strength and muscle fibre size, over 12 weeks of heavy weight training with creatine or placebo.
    Why it is on our label
    Our daily dose, over 12 weeks. Creatine monohydrate

    What it found

    AbsorptionMuscle creatine rose by 22% in the first week and was still higher than on placebo at week 12, on 5 g a day after the first week.

    In the bodyOn the same training, fat-free mass rose 6.3% on creatine against 3.1% on placebo, and bench press by 24% against 16%.

    Read the paperDOI 10.1097/00005768-199908000-00011

Nicotinamide riboside

What it did in people

  1. Randomised controlled trial

    133 people

    8 weeks

    Randomised controlled trial. 133 people. 8 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size133 people
    How long8 weeks

    Studied in: Ontario, Canada

    Dose 100, 300 or 1,000 mg a day

    Ours 300 mg

    Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults

    Conze et al., Scientific Reports, 2019

    Who
    Healthy men and women aged 40 to 60, with a body mass index of 25 to 30.
    What was measured
    NAD+ and related compounds in blood and urine over eight weeks of 100 mg, 300 mg or 1,000 mg a day, or placebo.
    Why it is on our label
    The trial at our exact dose, over eight weeks. Nicotinamide riboside

    What it found

    AbsorptionAt 300 mg a day, NAD+ in whole blood was 51% above its starting level after two weeks, and still 48% above it after eight.

    Funded by
    The NR maker; two authors work for it and a third is its chief scientific adviser.

    Read the paperDOI 10.1038/s41598-019-46120-z

Why it matters here

  1. Cross-sectional study

    49 people

    One measurement each

    Cross-sectional study. 49 people. One measurement each.
    The study in figures
    MeasureFigure
    DesignCross-sectional study
    Size49 people
    How longOne measurement each

    Studied in: Sydney, Australia

    Age-associated changes in oxidative stress and NAD+ metabolism in human tissue

    Massudi et al., PLoS ONE, 2012

    Who
    Surgical patients aged 15 to 77, and newborns.
    What was measured
    NAD+ and related markers in skin samples, against age.
    Why it is on our label
    One of the human tissue measurements behind the NAD range we print. Nicotinamide riboside

    What it found

    NAD+ in skin read lower with age.

    Funded by
    The researchers' own institutions; two authors direct a start-up in the same field.

    Read the paperDOI 10.1371/journal.pone.0042357

What it did in people

  1. Exploratory secondary analysis, no placebo group

    30 people

    5 months

    Exploratory secondary analysis, no placebo group. 30 people. 5 months.
    The study in figures
    MeasureFigure
    DesignExploratory secondary analysis, no placebo group
    Size30 people
    How long5 months

    Dose 1,000 mg a day

    Ours 300 mg, five days a week

    The Divergent Effects of Nicotinamide Riboside and High-Intensity Exercise Training on Skeletal Muscle Epigenetic Aging

    Heikkinen et al., Aging Cell, 2026

    Who
    Adults aged 30 to 65 from Finnish twin cohorts, most of them overweight.
    What was measured
    Epigenetic (DNA methylation) age in muscle and blood on seven clocks, including the muscle clock MEAT, before and after five months of nicotinamide riboside, with no placebo group.
    Why it is on our label
    A five-month result at more than three times our daily dose, from an exploratory analysis. Nicotinamide riboside

    What it found

    In the bodyIn muscle after five months, epigenetic age on the muscle clock (MEAT) was 2.49 years lower on average, and two other clocks fell with it; three did not change, and one rose by 0.50 years.

    Funded by
    Finnish public research funding and private foundations; the authors declare no conflicts.

    Read the paperDOI 10.1111/acel.70638

  2. Randomised crossover trial

    12 people

    Single doses, a week apart

    Randomised crossover trial. 12 people. Single doses, a week apart.
    The study in figures
    MeasureFigure
    DesignRandomised crossover trial
    Size12 people
    How longSingle doses, a week apart

    Studied in: Canada

    Dose 100, 300 and 1,000 mg, single doses

    Ours 300 mg

    Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

    Trammell et al., Nature Communications, 2016

    Who
    Twelve healthy adults aged 30 to 55, six men and six women, in the paper’s human trial.
    What was measured
    The NAD+ metabolome in blood over 24 hours after single doses of nicotinamide riboside.
    Why it is on our label
    Human data on the form our NAD precursor takes. Nicotinamide riboside

    What it found

    AbsorptionEach single dose raised the NAD+ family in the blood, more with each step up in dose. At 300 mg, NAD+ in blood cells rose by about 6.5 µM; at 1,000 mg, from about 12 to 18 µM.

    Funded by
    Research grants and the NR maker; some authors work for it or hold its shares.

    Read the paperDOI 10.1038/ncomms12948

Ubiquinol

What it did in people

  1. Randomised controlled trial

    62 people

    12 weeks

    Randomised controlled trial. 62 people. 12 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size62 people
    How long12 weeks

    Studied in: Japan

    Dose 100 or 150 mg a day

    Ours 100 mg

    serum ubiquinol from 1.00 to 2.96 µg/mL

    Ubiquinol-10 Intake Is Effective in Relieving Mild Fatigue in Healthy Individuals

    Mizuno et al., Nutrients, 2020

    Who
    Healthy adults aged 20 to 64.
    What was measured
    Serum ubiquinol over 12 weeks of 100 mg, 150 mg or placebo.
    Why it is on our label
    The trial at our exact dose. Ubiquinol

    What it found

    AbsorptionAt 100 mg a day, serum ubiquinol rose from 1.00 to 2.96 µg/mL within four weeks, against placebo.

    In the bodyAt 100 mg a day, fatigue after a mental task was lower than on placebo at four weeks, but not at eight or twelve.

    Funded by
    The ubiquinol maker, and in part a Japanese government research programme.

    Read the paperDOI 10.3390/nu12061640

  2. Fixed-order comparison, with a washout

    12 people

    12 weeks

    Fixed-order comparison, with a washout. 12 people. 12 weeks.
    The study in figures
    MeasureFigure
    DesignFixed-order comparison, with a washout
    Size12 people
    How long12 weeks

    Dose 200 mg a day

    Ours 100 mg

    Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone

    Langsjoen & Langsjoen, Clinical Pharmacology in Drug Development, 2014

    Who
    Healthy volunteers.
    What was measured
    Plasma CoQ10 after four weeks of each form, ubiquinone first and ubiquinol second.
    Why it is on our label
    Why we use ubiquinol rather than ubiquinone. Ubiquinol

    What it found

    AbsorptionAt the same dose, plasma CoQ10 rose from 0.9 to 2.5 µg/mL on ubiquinone and from 0.9 to 4.3 µg/mL on ubiquinol.

    Funded by
    The ubiquinol and ubiquinone maker, which also supplied both.

    Read the paperDOI 10.1002/cpdd.73

  3. Randomised crossover trial

    10 people

    6 weeks

    Randomised crossover trial. 10 people. 6 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised crossover trial
    Size10 people
    How long6 weeks

    Dose 200 mg a day

    Ours 100 mg

    Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men

    Zhang et al., Food & Function, 2018

    Who
    Older men.
    What was measured
    Ubiquinone and ubiquinol in plasma and in blood cells, after two weeks of each form.
    Why it is on our label
    Why we use ubiquinol rather than ubiquinone. Ubiquinol

    What it found

    AbsorptionTotal plasma CoQ10 rose from 1.3 to 3.4 µmol/L on ubiquinol; on ubiquinone the rise was too small to count.

    In the bodyNeither form changed the CoQ10 inside blood immune cells or the oxidative-stress markers measured.

    Read the paperDOI 10.1039/c8fo00971f

Glycine

What it did in people

  1. Randomised controlled trial

    24 people

    16 weeks

    Randomised controlled trial. 24 people. 16 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size24 people
    How long16 weeks

    Studied in: Texas, United States

    Dose 100 mg per kg of body weight a day, each of glycine and NAC

    Ours 6 g of glycine and 150 mg of NAC a day

    Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial

    Kumar et al., The Journals of Gerontology: Series A, 2023

    Who
    Adults aged 61 to 80 with a body mass index above 27.
    What was measured
    Glutathione in red blood cells, walking speed, grip strength, waist and blood pressure, over 16 weeks of glycine with NAC or placebo.
    Why it is on our label
    Glycine with NAC, both in our routine, at doses far above ours. Glycine

    What it found

    In the bodyGlutathione in red blood cells rose by 225% after 16 weeks; on placebo it did not change.

    In the bodyWalking speed rose from 1.13 to 1.34 m/s and grip strength from 32.3 to 36.7 kg; waist fell from 1.06 to 1.03 m and systolic blood pressure from 132.0 to 124.4 mmHg. On placebo none of these improved.

    Funded by
    US government research funding and a private foundation; the authors declare no conflicts.

    Read the paperDOI 10.1093/gerona/glac135

  2. Randomised crossover trial

    11 people

    Single doses, a week apart

    Randomised crossover trial. 11 people. Single doses, a week apart.
    The study in figures
    MeasureFigure
    DesignRandomised crossover trial
    Size11 people
    How longSingle doses, a week apart

    Studied in: Japan

    Dose 3 g, one dose

    Ours 3 g in the evening, 6 g a day

    Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes

    Yamadera et al., Sleep and Biological Rhythms, 2007

    Who
    Adults with poor sleep quality.
    What was measured
    Sleep recorded in a sleep lab, and how people rated their sleep the next morning, after 3 g of glycine or placebo before bed.
    Why it is on our label
    The study at our evening dose. Glycine
    Funded by
    Not stated; three of the six authors work for the glycine maker.

    Read the paperDOI 10.1111/j.1479-8425.2007.00262.x

  3. Randomised crossover trial

    7 people

    3 nights on each, 7 to 14 days apart

    Randomised crossover trial. 7 people. 3 nights on each, 7 to 14 days apart.
    The study in figures
    MeasureFigure
    DesignRandomised crossover trial
    Size7 people
    How long3 nights on each, 7 to 14 days apart

    Studied in: Japan

    Dose 3 g a day

    Ours 3 g in the evening, 6 g a day

    Bannai et al., Frontiers in Neurology, 2012

    Who
    Healthy men aged 30 to 61, all employees of the glycine maker.
    What was measured
    Daytime fatigue, sleepiness and reaction time after three nights of sleep cut by a quarter, with 3 g of glycine or placebo before bed.
    Why it is on our label
    Our evening dose, on the day after short nights. Glycine

    What it found

    In the bodyWith 3 g before bed, fatigue on the first day was rated lower, and reaction time on a vigilance test was faster on the first and third days, than on placebo.

    Funded by
    Not stated; three of the five authors worked for the glycine maker, and the volunteers were its employees.

    Read the paperDOI 10.3389/fneur.2012.00061

L-Ergothioneine

What it did in people

  1. Randomised dose comparison

    28 people

    8 weeks

    Randomised dose comparison. 28 people. 8 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised dose comparison
    Size28 people
    How long8 weeks

    Studied in: Tokyo, Japan

    Dose 5 or 10 mg a day

    Ours 5 mg

    plasma ergothioneine from 3.42 to 5.52 µM

    Estimation and Validation of an Effective Ergothioneine Dose for Improved Sleep Quality Using Physiologically Based Pharmacokinetic Model

    Okumura et al., Food Science & Nutrition, 2025

    Who
    Healthy adults.
    What was measured
    Ergothioneine in plasma and whole blood.
    Why it is on our label
    The study at our exact dose. L-Ergothioneine

    What it found

    AbsorptionAt 5 mg a day, plasma ergothioneine rose from 3.42 to 5.52 µM and whole-blood ergothioneine from 286 to 383 µM over eight weeks.

    Funded by
    A Japanese government research grant and the ingredient maker.

    Read the paperDOI 10.1002/fsn3.70382

Milk thistle

What it did in people

  1. Blinded crossover

    23 people

    Single doses, a week apart

    Blinded crossover. 23 people. Single doses, a week apart.
    The study in figures
    MeasureFigure
    DesignBlinded crossover
    Size23 people
    How longSingle doses, a week apart

    Studied in: Mexico

    Dose 70 mg, one dose

    Ours 75 mg

    Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers

    Méndez-Sánchez et al., BMC Pharmacology and Toxicology, 2019

    Who
    Healthy adults.
    What was measured
    Blood silybin after single doses of two milk thistle products.
    Why it is on our label
    What a dose close to ours delivers to the blood. Milk thistle

    What it found

    AbsorptionA single 70 mg dose of standard silymarin produced low blood levels of its main compound, silybin.

    Funded by
    The maker of the other product tested.

    Read the paperDOI 10.1186/s40360-018-0280-8

The studies that measured the liver were done in people with liver disease, at higher doses than ours, so none is listed here.

Lutein and zeaxanthin

What it did in people

  1. Randomised controlled trial

    109 people

    1 year

    Randomised controlled trial. 109 people. 1 year.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size109 people
    How long1 year

    Studied in: Georgia, United States

    Dose 10 mg + 2 mg a day

    Ours 10 mg + 2 mg

    A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast

    Hammond et al., Investigative Ophthalmology & Visual Science, 2014

    Who
    Healthy young adults.
    What was measured
    Blood lutein and zeaxanthin, and the pigment they form in the eye.
    Why it is on our label
    The trial at our exact dose. Lutein and zeaxanthin

    What it found

    AbsorptionBlood lutein and zeaxanthin rose within three months; on placebo they did not change. In the eye, the pigment they form rose by 0.10 units at one point of the retina over about 13 months.

    In the bodyRecovery from bright light and colour contrast improved against placebo.

    Funded by
    The two ingredient makers.

    Read the paperDOI 10.1167/iovs.14-15573

Astaxanthin

What it did in people

  1. Randomised controlled trial

    30 people

    12 weeks

    Randomised controlled trial. 30 people. 12 weeks.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size30 people
    How long12 weeks

    Studied in: Japan

    Dose 6 or 12 mg a day

    Ours 6 mg

    astaxanthin in red blood cells from 2.9 to 35.7 pmol/ml

    Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes

    Nakagawa et al., British Journal of Nutrition, 2011

    Who
    Healthy adults aged 50 to 69.
    What was measured
    Astaxanthin in red blood cells and plasma.
    Why it is on our label
    The trial at our exact dose. Astaxanthin

    What it found

    AbsorptionAt 6 mg a day, astaxanthin in red blood cells rose from 2.9 to 35.7 pmol/ml, and in plasma from 6 to 86 pmol/ml; on placebo neither moved.

    In the bodyAfter 12 weeks, a marker of fat oxidation in red blood cells was 8.0 pmol/ml at 6 mg a day and 9.7 at 12 mg, against 14.9 on placebo.

    Funded by
    A Japanese government research grant; one author works for the astaxanthin's maker.

    Read the paperDOI 10.1017/S0007114510005398

Collagen peptides

Why it matters here

  1. Cross-sectional study

    148 people

    One measurement each

    Cross-sectional study. 148 people. One measurement each.
    The study in figures
    MeasureFigure
    DesignCross-sectional study
    Size148 people
    How longOne measurement each

    The influence of age and sex on skin thickness, skin collagen and density

    Shuster, Black & McVitie, British Journal of Dermatology, 1975

    Who
    People the paper describes as normal subjects.
    What was measured
    Forearm skin collagen, skin thickness and collagen density.
    Why it is on our label
    The source of the collagen measurement we print. Collagen peptides

    What it found

    Skin collagen fell in a near-straight line, about 1% a year of adult life.

    Read the paperDOI 10.1111/j.1365-2133.1975.tb05113.x

What it did in people

  1. Randomised crossover trial

    6 people

    Single doses, a week apart

    Randomised crossover trial. 6 people. Single doses, a week apart.
    The study in figures
    MeasureFigure
    DesignRandomised crossover trial
    Size6 people
    How longSingle doses, a week apart

    Studied in: Esslingen, Germany

    Dose 10 g, one dose

    Ours 10 g

    Absorption of bioactive peptides following collagen hydrolysate intake: a randomized, double-blind crossover study in healthy individuals

    Virgilio et al., Frontiers in Nutrition, 2024

    Who
    Healthy adults.
    What was measured
    Collagen markers in blood plasma after a 10 g dose of four collagens.
    Why it is on our label
    How a 10 g dose, our dose, reaches the blood. Collagen peptides

    What it found

    AbsorptionAfter a single 10 g dose, free hydroxyproline, a collagen marker, rose 6 to 10 times in the blood within about two hours, and 36 to 47% of all hydroxyproline in the blood was still bound in small peptides.

    Funded by
    The collagen maker.

    Read the paperDOI 10.3389/fnut.2024.1416643

  2. Crossover trial

    4 people

    Single doses, a week apart

    Crossover trial. 4 people. Single doses, a week apart.
    The study in figures
    MeasureFigure
    DesignCrossover trial
    Size4 people
    How longSingle doses, a week apart

    Dose 2, 10 and 25 g, single doses

    Ours 10 g

    Dose-dependent changes in the levels of free and peptide forms of hydroxyproline in human plasma after collagen hydrolysate ingestion

    Shigemura et al., Food Chemistry, 2014

    Who
    Healthy adults.
    What was measured
    Collagen markers in blood plasma after single doses.
    Why it is on our label
    How collagen peptides reach the blood. Collagen peptides

    What it found

    AbsorptionAfter a single dose, collagen peptides appeared in the blood within about 2 hours, more with each larger dose; about a quarter of the collagen marker in the blood arrived still in peptide form.

    Funded by
    A Japanese government research grant; the collagen was donated by its maker.

    Read the paperDOI 10.1016/j.foodchem.2014.02.091

Omega-3 (EPA + DHA)

Why it matters here

  1. Review of published measurements

    342,864 people

    Samples drawn after 1999

    Review of published measurements. 342,864 people. Samples drawn after 1999.
    The study in figures
    MeasureFigure
    DesignReview of published measurements
    Size342,864 people
    How longSamples drawn after 1999

    Pooled from 48 countries

    Omega-3 world map: 2024 update

    Schuchardt et al., Progress in Lipid Research, 2024

    Who
    People in clinical trials and observational studies worldwide.
    What was measured
    The omega-3 index in red blood cells, mapped by country and region.
    Why it is on our label
    The update behind the omega-3 figures we print. Omega-3 (EPA + DHA)

    What it found

    Most of the world was still low or very low; about three quarters of countries had no data.

    Funded by
    In part, the omega-3 industry's trade body, which employs two authors; one author holds shares in a fatty-acid testing lab.

    Read the paperDOI 10.1016/j.plipres.2024.101286

What it did in people

  1. Randomised controlled trial

    115 people

    About 5 months

    Randomised controlled trial. 115 people. About 5 months.
    The study in figures
    MeasureFigure
    DesignRandomised controlled trial
    Size115 people
    How longAbout 5 months

    Studied in: Pennsylvania, United States

    Dose 0 to 1,800 mg a day

    Ours 1,200 mg

    Determinants of Erythrocyte Omega-3 Fatty Acid Content in Response to Fish Oil Supplementation: A Dose-Response Randomized Controlled Trial

    Flock et al., Journal of the American Heart Association, 2013

    Who
    Healthy adults.
    What was measured
    The omega-3 index across five daily doses.
    Why it is on our label
    The dose-response behind our omega-3 dose. Omega-3 (EPA + DHA)

    What it found

    AbsorptionThe omega-3 index rose in step with the dose taken.

    Funded by
    A US government research grant; an omega-3 maker donated the supplements tested.

    Read the paperDOI 10.1161/JAHA.113.000513

Why it matters here

  1. Review of published measurements

    298 studies

    Studies published from 1980

    Review of published measurements. 298 studies. Studies published from 1980.
    The study in figures
    MeasureFigure
    DesignReview of published measurements
    Size298 studies
    How longStudies published from 1980

    Pooled from 54 countries

    Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults

    Stark et al., Progress in Lipid Research, 2016

    Who
    Healthy adults, in studies published worldwide.
    What was measured
    Blood EPA and DHA, mapped by country and region.
    Why it is on our label
    The survey behind the omega-3 bands we print. Omega-3 (EPA + DHA)

    What it found

    The Middle East sat in the lowest omega-3 index band, 4% or below.

    Funded by
    An omega-3 maker, which employs one author.

    Read the paperDOI 10.1016/j.plipres.2016.05.001

The vitamins and minerals

The other vitamins and minerals are set from the European reference intakes, or held under a tolerable upper level, not from trial doses. The reference for each is printed on the ingredients page.

Ingredients

The Founding 500

This is for people who would rather keep one small thing every day than start a big thing every January.

Be one of the first five hundred.

Leave your email and you will hear from us twice: one short note as launch nears, and once when the first batch is ready. Founding members who pay for the year pay at least 25% less than the monthly price, and every founding member keeps their price for at least the first two years.

One confirmation email to make sure it is really you, one short note as launch nears, and nothing else until launch. We take the country your signup came from, nothing more. Unsubscribe in one click, any time.

Protected by Cloudflare Turnstile: a security check with no tracking cookies and no profiling.